Literature DB >> 23597489

Novel insights into ChREBP regulation and function.

Gaëlle Filhoulaud1, Sandra Guilmeau, Renaud Dentin, Jean Girard, Catherine Postic.   

Abstract

Glucose is an energy source that also controls the expression of key genes involved in energetic metabolism through the glucose-signaling transcription factor carbohydrate response element-binding protein (ChREBP). ChREBP has recently emerged as a central regulator of glycolysis and de novo fatty acid synthesis in liver, but new evidence shows that it plays a broader and crucial role in various processes, ranging from glucolipotoxicity to apoptosis and/or proliferation in specific cell types. However, several aspects of ChREBP activation by glucose metabolites are currently controversial, as well as the effects of activating or inhibiting ChREBP, on insulin sensitivity, which might depend on genetic, dietary or environmental factors. Thus, much remains to be elucidated. Here, we summarize our current understanding of the regulation and function of this fascinating transcription factor.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23597489     DOI: 10.1016/j.tem.2013.01.003

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  76 in total

Review 1.  Exploring the emerging complexity in transcriptional regulation of energy homeostasis.

Authors:  Adelheid Lempradl; J Andrew Pospisilik; Josef M Penninger
Journal:  Nat Rev Genet       Date:  2015-10-13       Impact factor: 53.242

Review 2.  Intersections of post-transcriptional gene regulatory mechanisms with intermediary metabolism.

Authors:  Waqar Arif; Gandhar Datar; Auinash Kalsotra
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-11       Impact factor: 4.490

Review 3.  Hepatic glucose sensing and integrative pathways in the liver.

Authors:  Maaike H Oosterveer; Kristina Schoonjans
Journal:  Cell Mol Life Sci       Date:  2013-11-07       Impact factor: 9.261

4.  Chrebp regulates the transcriptional activity of androgen receptor in prostate cancer.

Authors:  Xue-Lei Wang; Xiao-Fei Wen; Rong-Bing Li; Bin Liu; Guang-Ming Qiu; Ji-Ling Wen; Yue-Min Wang
Journal:  Tumour Biol       Date:  2014-05-21

5.  Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3/adiponutrin in mouse liver and HepG2 human liver cells.

Authors:  Lei Hao; Kyoko Ito; Kuan-Hsun Huang; Sudathip Sae-tan; Joshua D Lambert; A Catharine Ross
Journal:  Metabolism       Date:  2014-06-21       Impact factor: 8.694

6.  NURR1 activation in skeletal muscle controls systemic energy homeostasis.

Authors:  Leonela Amoasii; Efrain Sanchez-Ortiz; Teppei Fujikawa; Joel K Elmquist; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-20       Impact factor: 11.205

Review 7.  Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Authors:  Donald B Jump; Kelli A Lytle; Christopher M Depner; Sasmita Tripathy
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

8.  ChREBP regulates fructose-induced glucose production independently of insulin signaling.

Authors:  Mi-Sung Kim; Sarah A Krawczyk; Ludivine Doridot; Alan J Fowler; Jennifer X Wang; Sunia A Trauger; Hye-Lim Noh; Hee Joon Kang; John K Meissen; Matthew Blatnik; Jason K Kim; Michelle Lai; Mark A Herman
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

9.  Glucokinase activity in the arcuate nucleus regulates glucose intake.

Authors:  Syed Hussain; Errol Richardson; Yue Ma; Christopher Holton; Ivan De Backer; Niki Buckley; Waljit Dhillo; Gavin Bewick; Shuai Zhang; David Carling; Steve Bloom; James Gardiner
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

10.  Decreased genetic dosage of hepatic Yin Yang 1 causes diabetic-like symptoms.

Authors:  Francisco Verdeguer; Sharon M Blättler; John T Cunningham; Jessica A Hall; Helen Chim; Pere Puigserver
Journal:  Mol Endocrinol       Date:  2014-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.